Spine Journal - 2026-10-21 - Journal Article
Outcomes after Posterior Cervical Spine Surgery: A Matched Cohort Analysis and Comparison of GLP-1 Receptor Agonist Use and Bariatric Surgery in Patients with Type 2 Diabetes.
Rivera N, Bradley T, Crowell KA, Goodwin CR, Erickson M
Topics
Key Takeaway
Preoperative GLP-1 RA use in type 2 diabetic patients undergoing posterior cervical spine surgery was associated with 43% lower odds of revision surgery at 90 days (OR 0.33) and 69% lower odds at 2 years (OR 0.31) compared to matched controls.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This retrospective propensity-score matched database study compared perioperative and postoperative outcomes in type 2 diabetic patients on metformin undergoing posterior cervical spine surgery, stratified into GLP-1 RA users, non-GLP-1 controls, and prior bariatric surgery patients. GLP-1 users had significantly lower odds of perioperative pneumonitis (OR 0.57), 90-day SSI (OR 0.72), 90-day readmission (OR 0.82), and 2-year nutritional deficiency (OR 0.62) versus matched controls. Outcomes between GLP-1 users and prior bariatric surgery patients were statistically equivalent across all measured endpoints.
Key Limitation
Administrative claims-based design precludes verification of GLP-1 RA adherence, duration, or dose, and cannot exclude selection bias whereby healthier, more metabolically controlled diabetic patients were preferentially prescribed GLP-1 RAs.
Original Abstract
BACKGROUND CONTEXT
Obesity and diabetes can increase perioperative risk, especially in posterior cervical spine surgery. Bariatric surgery provides durable weight loss but carries surgical and nutritional risks, while glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are non-surgical alternatives that may optimize weight and metabolic status preoperatively. Evidence evaluating GLP-1 therapy in spine surgery is limited.
PURPOSE
To evaluate associations between preoperative GLP-1 RA use and perioperative, short-term, and long-term complications following posterior cervical spine surgery in patients with type 2 diabetes, including comparisons to matched controls and patients with prior bariatric surgery.
STUDY DESIGN
Retrospective database analysis.
PATIENT SAMPLE
Patients with type 2 diabetes treated with metformin undergoing posterior cervical spine surgery between 2010 and 2023 were identified in the PearlDiver Mariner database. Patients were stratified into GLP-1 users, non-GLP-1 controls, and patients with prior bariatric surgery.
OUTCOME MEASURES
Physiologic measures included perioperative outcomes and postoperative complications assessed at 90 days and 2 years, including pneumonitis, surgical site infection, revision surgery, readmission, nutritional deficiency, and other medical and surgical complications.
METHODS
The PearlDiver Mariner database was queried for eligible patients. Propensity-score matching adjusted for baseline cohort differences. Outcomes included perioperative, 90-day, and 2-year complications, with BMI-stratified analyses conducted within the matched GLP-1 and control cohort. Benjamini-Hochberg false discovery rate correction was applied for multiple comparisons.
RESULTS
GLP-1 users demonstrated lower odds of perioperative complications, including pneumonitis (OR 0.57; 95% CI 0.43-0.75; p <0.001). At 90 days, GLP-1 users experienced reduced odds of surgical site infection (OR 0.72; 95% CI 0.65-0.80; p <0.001), revision surgery (OR 0.33; 95% CI 0.29-0.36; p <0.001), readmission (OR 0.82; 95% CI 0.76-0.90; p <0.001), and other complications. At 2 years, GLP-1 users had lower odds of revision surgery (OR 0.31; 95% CI 0.28-0.34; p <0.001), nutritional deficiency (OR 0.62; 95% CI 0.59-0.66; p <0.001), and other complications. Exploratory BMI-stratified analyses suggested similar directional trends across overweight and obese patients. Comparisons to prior bariatric surgery patients showed no significant differences.
CONCLUSIONS
Preoperative GLP-1 RA use was associated with reduced perioperative, short-term, and long-term complications following posterior cervical spine surgery in patients with type 2 diabetes. When compared with a matched bariatric surgery cohort, no significant differences in postoperative outcomes were observed. These findings should be interpreted in the context of potential residual confounding and support further prospective investigation of GLP-1 therapy as a strategy for preoperative metabolic optimization in posterior cervical spine surgery.
CLASSIFICATIONS
Cervical Spine, Outcomes Research, Risk Factors, Perioperative Complications.